Revolution Medicines, Inc.

Revolution Medicines (RVMDW) has recorded zero cyber incidents and zero red-flag 8-K filings in the past 90 days, indicating operational stability in our near-term detection window. However, low signal in a 90-day window does not mean low risk; biotech warrant holders face structural vulnerabilities that require deeper analysis. The full $49 Report extends review to 12 months of filings, adds dilution risk scoring, financing history, and AI-detected risk signals across management and balance sheet trends. The full $49 Report adds quantified dilution probability, historical financing patterns, and forward risk indicators for informed warrant positioning.